96981 ⎘
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans Hormones
Benzocyanine compounds
#302Compounds and methods for conjugation of biomolecules
#303Radiation - Sterilized Biodegradable Drug Delivery Compositions
#304Therapeutic fusion proteins
#305Angiopoietin-like protein 8 polypeptide fragments and compositions thereof
#306Composition comprising a polymeric reagent
#307METHODS OF PRODUCING AND PURIFYING MATRIX-BINDING FUSION PROTEINS BY ION-EXCHANGE CHROMATOGRAPHY
#308Superagonist polypeptide analogs of adrenomedullin and intermedin peptide hormones
#309Apelin peptides and uses thereof
#310Polypeptide for inhibition of tumor
#311ANALOGUES OF HEPCIDIN MIMETICS WITH IMPROVED IN VIVO HALF LIVES
#312METHODS AND COMPOSITIONS RELATED TO IMPROVING PROPERTIES OF PHARMACOLOGICAL AGENTS TARGETING NERVOUS SYSTEM
#313Biodegradable polymeric nanoparticle conjugates and use thereof
#314Co-agonists of the glucagon and GLP-1 receptors
#315Cysteine analogs of exendin-4
#316Method of using carbohydrate esters as inducers for gene expression
#317Translatable molecules and synthesis thereof
#318Islet amyloid polypeptides with improved solubility
#319Cortistatin analogues and syntheses and uses thereof
#320STABILIZED BIOACTIVE PEPTIDES AND METHODS OF IDENTIFICATION, SYNTHESIS, AND USE
#321Polyalkoxy fatty compound
#322Engineered Polypeptides Having Enhanced Duration of Action and Reduced Immunogenicity
#323Selection methods for genetically-modified T cells
#324N-Terminal Polysialylation
#325Inhibin analogs
#326ADHD MARKER, APPLICATION THEREOF AND KIT
#327Polypeptides, nucleic acids and uses thereof
#328Long-acting adrenomedullin derivative
#329Methods of treating eye disorders with APLNR antagonists and VEGF inhibitors
#330Polyalkoxy fatty compound
#331Composition for treating diabetes or diabesity comprising oxyntomodulin analog
#332PROTEIN THERAPY FOR TREATMENT OF RETINAL DISEASES
#333ANTIBODY THAT BINDS MURINE WISE PROTEIN
#334Long-acting adrenomedullin derivatives
#335Methods to Treat Diseases with Protein, Peptide, Antigen Modification and Hemopurification
#336Compounds as peptidic GLP1/glucagon/GIP receptor agonists
#337Compounds as peptidic trigonal GLP1/glucagon/GIP receptor agonists
#338Variants of adrenomedullin and calcitonin gene-related peptide and methods of use
#339ESCHERICHIA COLI T7 EXPRESSION VECTOR, VECTORS FOR THE CO-EXPRESSION AND CO-PURIFICATION OF RECOMBINANT PEPTIDES IN/WITH CARRIER PROTEINS, USE OF EXPRESSION VECTORS FOR OBTAINING COMPLEXES WITH MULTIPLE ANTIGENS AND IMMONOMODULATORS
#340Brain penetrant amylin receptor based peptides for Alzheimer's disease
#341Method for producing myocardial cells using synthetic peptide
#342Cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptors
#343Immunoglobulins and uses thereof
#344Human catestatin induces gut microbiota dysbiosis
#345Antibody-coupled cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptors
#346Isolated adipose-derived mesenchymal stem cells treated with angelica extract or butylidenephthalide, and wherein the cells have an increased mitochondrial membrane potential and a decreased level of IL-8, and methods for treating parkinson's disease
#347METHODS OF PRODUCING LONG ACTING CTP-MODIFIED GROWTH HORMONE POLYPEPTIDES
#348HEPCIDIN ANALOGUES AND USES THEREOF
#349METHOD FOR REDUCING THE IMMUNE RESPONSE TO A BIOLOGICALLY ACTIVE PROTEIN
#350Hepcidin analogues and uses thereof
#351Amylin analogues
#352Anti-hepcidin antibodies and uses thereof
#353Cyclic galanin-analogs and uses thereof
#354STERILE MALE INSECTS THAT SIGNIFICANTLY REDUCE LIFESPAN AND EGG-PRODUCTION OF MATED WILD-TYPE FEMALE INSECTS
#355Microbe transformant for weight loss and lipid reduction, the method for constructing the transformant, and application thereof
#356Messenger UNA molecules and uses thereof
#357OREXIN-B POLYPEPTIDES AND USES THEREOF
#358Pharmaceutical preparation comprising recombinant HcG
#359Fatty acid modified urocortin-2 analogs for the treatment of diabetes and chronic kidney disease
#360Compositions of active WNT protein
#361Mirac proteins
#362S-Alkylated Hepcidin Peptides and Methods of Making and Using Thereof
#363Production Of Glycoproteins Using Manganese
#364METHODS AND MEANS FOR DETERMINING TREATMENT OF SUBJECTS WITH EXOGENOUS SOMATOTROPIN
#365Composition comprising a polymeric reagent
#366Oxyntomodulin derivatives and pharmaceutical composition for treating obesity comprising the same
#367USE OF RELAXIN TO TREAT ATRIAL FIBRILLATION
#368Melanocortin ligands and methods of use thereof
#369Conjugate comprising oxyntomodulin and an immunoglobulin fragment, and use thereof
#370Bioengineered adipocytes for the light-controlled release of insulin and other peptides
#371FUSION PROTEINS AND METHODS FOR TREATING, PREVENTING OR AMELIORATING PAIN
#372Satiation peptides for weight loss and altered taste sensitivity
#373HEPCIDIN AND MINI-HEPCIDIN ANALOGUES AND USES THEREOF
#374Methods and Pharmaceutical Composition for the Preservation of Vascular Endothelial Cell Barrier Integrity
#375Humanized anti-PACAP antibodies and uses thereof
#376Nucleic acid constructs for presentation of CD4 and CD8 epitopes, cellular transfection and uses thereof
#377Anti-hepcidin antibodies and uses thereof
#378Incretin-insulin conjugates
#379Peptide conjugates of GLP-1 receptor agonists and gastrin and their use
#380PROTEIN THERAPY FOR TREATMENT OF RETINAL DISEASES
#381Propeptide-luciferase fusion proteins and methods of use thereof
#382Stabilized insulinotropic peptides and methods of use
#383Tumor necrosis factor superfamily and TNF-like ligand muteins and methods of preparing
#384GIP agonist compounds and methods
#385Ras inhibitory peptides and uses thereof
#386Protein and protein conjugate for diabetes treatment, and applications thereof
#387INSULINOTROPIC PEPTIDE DERIVATIVE WITH MODIFIED N-TERMINAL CHARGE
#388Solid phase peptide synthesis
#389Methods for treating cardiovascular dysfunction and improving fluid homeostasis with Elabela peptide hormone
#390PROTEOLICALLY RESISTANT CYCLOTIDES WITH ANGIOTENSIN 1-7 LIKE ACTIVITY
#391METHODS OF TREATING DIABETES AND COMPOSITIONS CAPABLE OF SAME
#392Conditionally active biological proteins
#393Carrier immunoglobulins
#394Oxyntomodulin analogue
#395Methods to Treat Diseases with Protein, Peptide, Antigen Modification and Hemopurification
#396Benzocyanine Compounds
#397Serum albumin binding molecules
#398Method of promoting bone growth by an anti-actriia antibody
#399Phoenixin peptides
#400Amylin and calcitonin receptor agonist
#401Methods for treatment of conditions associated with elevated triglycerides with an ANGPTL8 polypeptide fragment
#402PEPTIDE YY (PYY) ANALOGUES
#403METHOD FOR REDUCING THE IMMUNE RESPONSE TO A BIOLOGICALLY ACTIVE PROTEIN
#404METHODS OF TREATING NEURODEGENERATIVE CONDITIONS
#405ENGINEERED POLYPEPTIDES HAVING ENHANCED DURATION OF ACTION
#406POLYPEPTIDES AS APELIN INHIBITORS AND USES THEREOF
#407ACTH prophylactic treatment of renal disorders
#408LONG-ACTING OXYNTOMODULIN VARIANTS AND METHODS OF PRODUCING SAME
#409Stabilizied bioactive peptides and methods of identification, synthesis and use
#410Apelin analogues
#411N-terminal derivatisation of proteins with polysaccharides
#412Islet amyloid polypeptides with improved solubility
#413LIPIDATED PEPTIDES AS NEUROPROTECTIVE AGENTS
#414Process for the purification of a growth factor protein
#415Mirac proteins
#416LONG-ACTING STABLE PEPTIDE GHRELIN ANALOGS FOR THE TREATMENT OF CACHEXIA
#417Composition and Methods for Stimulating Gastrointestinal Motility
#418Anti-obesity compounds derived from neuromedin U
#419Cortistatin analogues and syntheses and uses thereof
#420Oxyntomodulin derivatives and pharmaceutical composition for treating obesity comprising the same
#421LONG ACTING PROTEINS AND PEPTIDES AND METHODS OF MAKING AND USING THE SAME
#422Long-acting peptide analogs
#423Solid phase peptide synthesis via side chain attachment
#424Composition comprising a polymeric reagent
#425Derivative of styrene-maleic acid copolymer
#426Polypeptides, nucleic acids and uses thereof
#427Application of irisin in myocardial ischemia reperfusion
#428Methods for stimulation of appetite and increase in weight by administration of asprosin
#429Selective PYY compounds and uses thereof
#430Amylin analogues
#431Amylin and calcitonin receptor agonist
#432HPYY(1-36) having a beta-homoarginine substitution at position 35
#433Nucleic acids encoding for chimeric natriuretic polypeptides with unique pharmacologic profiles
#434Tissue protective peptides and uses thereof
#435Lipidated peptides for lowering blood glucose
#436Viral vectors for expressing a modified mullerian inhibiting substance (MIS) protein
#437Composition comprising peptide derived from adiponectin
#438Hepcidin analogues and uses thereof
#439Engineered polypeptides having enhanced duration of action and reduced immunogenicity
#440AMINO DIACIDS CONTAINING PEPTIDE MODIFIERS
#441Modified mini-hepcidin peptides and methods of using thereof
#442Fusion proteins comprising FGF-21 and GLP-1R agonist
#443Cortistatin analogues for the treatment of inflammatory and/or immune diseases
#444NON-AGGLOMERATING BIOCONJUGATES OF AMYLIN AND AMYLIN-MIMETIC COMPOUNDS, COMPOSITIONS COMPRISING THE SAME, AND MAKING AND USE THEREOF
#445Peptide conjugates of GLP-1 receptor agonists and gastrin and their use
#446Recombinant protein
#447Benzocyanine compounds
#448METHODS OF PRODUCING LONG ACTING CTP-MODIFIED POLYPEPTIDES
#449PROCESS FOR PREPARING AMPHIPHILIC PEPTIDE DERIVATIVES
#450Stabilized insulinotropic peptides and methods of use
#451Methods for producing sialylated therapeutic proteins
#452Fusion Proteins With Dual Receptor Agonist Activities
#453GAS57 MUTANT ANTIGENS AND GAS57 ANTIBODIES
#454Method of modulating sex hormone levels using a sex hormone secretion modulator
#455MESSENGER UNA MOLECULES AND USES THEREOF
#456Antibodies to human resistin
#457Derivatisation of erythropoietin (EPO)
#458Derivatisation of erythropoietin (EPO)
#459Method of identifying an agent that promotes bone growth or increases bone density
#460Compositions of active Wnt protein
#461Methods for producing peptides using engineered inteins
#462Derivatisation of granulocyte colony-stimulating factor
#463Method for producing natively folded proteins in a prokaryotic host
#464NOVEL PEPTIDYL ALPHA-HYDROXYGLYCINE ALPHA-AMIDATING LYASES
#465Chimeric leptin polypeptide and method of using the same
#466Modified proteins and methods of use thereof
#467Modified Mullerian inhibiting substance (MIS) proteins and uses thereof for the treatment of diseases
#468Therapeutic agents comprising a GLP-2 peptide and elastin-like peptides
#469Methods for preparing polymeric reagents
#470Anti-hepcidin antibodies and uses thereof
#471Bovine fusion antibodies
#472Methods of treatment using natriuretic polypeptides
#473GAMMA-MSH ANALOGUES
#474Stanniocalcin-1 (STC-1) therapy for treatment of retinal diseases
#475Method for the control of nematodes in plants
#476KISS1R receptor agonist compounds and use thereof for inducing ovulation in mammals
#477Compositions of active Wnt protein
#478Albumin fusion proteins
#479Insulinotropic peptide derivative with modified N-terminal charge
#480Phoenixin peptides
#481Method of increasing natriuretic activity by administering natriuretic polypeptides with unique pharmacologic profiles
#482METHOD OF PRODUCING A RECOMBINANT PEPTIDE
#483Oxyntomodulin analogs
#484Composition for long-acting peptide analogs
#485NOVEL PEPTIDE AND APPLICATION THEREOF
#486A COMPOSITION FOR TREATING DIABETES OR DIABESITY COMPRISING OXYNTOMODULIN ANALOG
#487GIP-GLP-1 dual agonist compounds and methods
#488Oxyntomodulin derivatives and pharmaceutical composition for treating obesity comprising the same
#489Glucose-regulating polypeptides and methods of making and using same
#490THERAPEUTIC AGENT FOR AMYOTROPHIC LATERAL SCLEROSIS
#491Derivatisation of granulocyte colony-stimulating factor
#492Bioreversable promoieties for nitrogen-containing and hydroxyl-containing drugs
#493USE OF RELAXIN TO TREAT ATRIAL FIBRILLATION
#494Albumin fusion proteins
#495Methods and compositions related to improving properties of pharmacological agents targeting nervous system
#496Compositions and methods for brown fat induction and activity using FNDC5
#497FUSION PROTEINS AND METHODS FOR TREATING, PREVENTING OR AMELIORATIONG PAIN
#498OX40L fusion protein for the immunotherapy of tumors of veterinary animals
#499Protein and protein conjugate for diabetes treatment, and applications thereof
#500Lipidated peptides as anti-obesity agents
#501Exendin-4 Peptide Analogues
#502Derivatisation of erythropoietin (EPO)
#503Polypeptides, nucleic acids and uses thereof
#504Carbohydrate esters as inducers for gene expression
#505Antibody that binds murine wise protein
#506Serum albumin binding molecules
#507METHOD FOR HARVESTING ORGANIC COMPOUNDS FROM GENETICALLY MODIFIED ORGANISMS
#508N-terminal derivatisation of proteins with polysaccharides
#509Pancreatic Peptide Compounds and Use
#510PARENTERAL PHARMACEUTICAL COMPOSITION CONTAINING COSYNTROPIN
#511USE OF OBESTATIN FOR MUSCLE REGENERATION
#512Methods for promoting lipolysis and oxidation in liver and adipose tissue using catestatin
#513NOVEL SEQUENCES FOR THE CONTROL OF REPRODUCTION IN FISH
#514Modified apelin polypeptides
#515GLP-1, exendin-4, peptide analogs and uses thereof
#516Long-acting oxyntomodulin variants and methods of producing same
#517FGF-2 variants and methods of use thereof
#518Compounds and Methods for Conjugation of Biomolecules
#519GLP-1 prodrugs
#520Carrier immunoglobulins
#521Carrier immunoglobulins
#522Modified Adiponectin Polypeptides and Their Uses
#523Diagnosis and risk stratification by determining the marker CT-proADM
#524Mirac proteins
#525Artificial signal peptide for expressing an insoluble protein as a soluble active form
#526REPEATED ADMINISTRATION OF NON-IMMUNOSUPPRESSIVE ANTIGEN SPECIFIC IMMUNOTHERAPEUTICS
#527Mirac proteins
#528Modified mini-hepcidin peptides and methods of using thereof
#529MODULATION OF GHRELIN LEVELS AND GHRELIN/UNACYLATED GHRELIN RATIO USING UNACYLATED GHRELIN
#530ACTH prophylactic treatment of renal disorders
#531Molecule capable of binding to adrenocorticotropic hormone, and use thereof
#532QUANTIFICATION OF TRANSTHYRETIN AND ITS ISOFORMS
#533Derivatisation of erythropoietin (EPO)
#534Derivatisation of erythropoietin (EPO)
#535Compositions of active Wnt protein
#536MODULATION OF PANCREATIC BETA CELL PROLIFERATION
#537Propeptide-luciferase fusion proteins and methods of use thereof
#538METHOD FOR REDUCING THE IMMUNE RESPONSE TO A BIOLOGICALLY ACTIVE PROTEIN
#539Radiation-Sterilized Biodegradable Drug Delivery Composition
#540Polyethylene glycol based prodrug of adrenomedullin and use thereof
#541Protein therapy for treatment of retinal diseases
#542ENGINEERED POYPEPTIDES HAVING ENHANCED DURATION OF ACTION AND REDUCED IMMUNOGENICITY
#543Treatment and Prevention of Gastrointestinal Syndrome
#544Hybrid polypeptides with selectable properties
#545Pharmaceutical preparation comprising recombinant HcG
#546Nanoparticle peptide compositions
#547Solid phase peptide synthesis via side chain attachment
#548Bovine fusion antibodies
#549DRUG FUSIONS AND CONJUGATES WITH EXTENDED HALF LIFE
#550Amylin Peptides and Derivatives and Uses Thereof
#551Suppression of prostate cancer using a targeted clostridial neurotoxin
#552Conjugate comprising oxyntomodulin and an immunoglobulin fragment, and use thereof
#553WNT COMPOSITIONS AND METHODS OF USE THEREOF
#554Mirac proteins
#555Phoenixin peptides
#556Glucose dependent insulinotropic polypeptide analogs, pharmaceutical compositions and use thereof
#557Derivatisation of granulocyte colony-stimulating factor
#558Long-acting peptide analogs
#559Therapeutic fusion proteins
#560Ghrelin analogs
#561SOGA polynucleotides and polypeptides and uses thereof
#562N-terminal derivatisation of proteins with polysaccharides
#563Oxyntomodulin derivatives and pharmaceutical composition for treating obesity comprising the same
#564Methods for preparing polymeric reagents
#565DNA vaccine
#566Production of glycoproteins using manganese
#567Amylin analogs and pharmaceutical compositions thereof
#568Ghrelin mimetic polypeptide hapten immunoconjugates having improved solubility and immunogenicity and methods of use thereof
#569Isolated polynucleotide that encodes an ActRIIa-Fc fusion polypeptide
#570Antibodies to TTR and methods of use
#571FUSION PROTEINS
#572Single chain relaxin polypeptides
#573Expression system with SAR element from IFNα2
#574COMPOSITIONS, METHODS AND KITS RELATING TO RESISTIN
#575Amylin analogues and pharmaceutical compositions thereof
#576Peptides derivatized with A-B-C-D- and their therapeutical use
#577FGF-9 variants and methods of use thereof
#578Antibodies that bind to adrenomedullin and to adrenomedullin receptors and the uses thereof as drugs
#579Compounds and their effects on feeding behaviour
#580Pancreatic polypeptide family motifs, polypeptides and methods comprising the same
#581Chimeric aquaretic and natriuretic polypeptides lacking vasodilatory activity
#582Biomarkers for pneumonia and acute decompensated heart failure
#583Method of promoting bone growth by an anti-actriia antibody
#584Glucagon-like peptide-1 glycopeptides
#585Amylin analogues and pharmaceutical compositions thereof
#586Pharmaceutical for Pseudo-Exercise Therapy
#587Diagnosis and risk stratification by determining the marker CT-proADM
#588Methods for treatment of nephrotic syndrome and related conditions
#589Methods and compositions related to improving properties of pharmacological agents targeting nervous system
#590Immunoassay for detecting thyroglobulin utilizing soybean produced recombinant thyroglobulin
#591SITE-SPECIFIC CHEMICAL MODIFICATION OF PROTEINS AT THEIR N-TERMINI, ENABLING THE FORMATION OF HOMOGENEOUS ADDUCTS
#592Method for increasing plant biomass
#593HIGHLY SOLUBLE LEPTINS
#594GIP analog and hybrid polypeptides with selectable properties
#595Methods for preparing conjugates
#596Modified ghrelin peptides
#597TARGETING COMPOUNDS
#598ORAL INSULIN THERAPY
#599Stabilized insulinotropic peptides and methods of use
#600Modulation of ghrelin levels and ghrelin/unacylated ghrelin ratio using unacylated ghrelin